Free tool
Dividend paying stocks
We cover 92 companies that currently pay a dividend. The median market value in the group is $60.58B. Across the group, the median move over the past trading day is −0.09%. 67% of the 92 with a 200-day average trade above it. Price change over the past year runs from −20.3% to +52.0% across the middle 80 percent of the group, with a median of +7.5%.
Other lists in this group
Table
92 of 9,852 companies match these filters.Clear filters
| Ticker | Company | Market cap (USD) | Size | 1Y return |
|---|---|---|---|---|
| LILY34.SA | Eli Lilly and Company | $1.10T | Mega cap | +59.83% |
| LLY | Eli Lilly and Company | $1.06T | Mega cap | +62.80% |
| JNJ | Johnson & Johnson | $658.24B | Mega cap | +55.40% |
| JNJB34.SA | Johnson & Johnson | $658.09B | Mega cap | +47.82% |
| ABBV | AbbVie Inc. | $469.68B | Mega cap | +29.36% |
| ABBV34.SA | AbbVie Inc. | $467.00B | Mega cap | +21.88% |
| MRCK34.SA | Merck & Co., Inc. | $388.60B | Mega cap | +81.07% |
| MRK | Merck & Co., Inc. | $377.72B | Mega cap | +86.85% |
| N1VS34.SA | Novartis AG | $301.83B | Mega cap | +20.04% |
| NVS | Novartis AG | $299.44B | Mega cap | +27.93% |
| AZN | AstraZeneca PLC | $263.12B | Mega cap | +5.09% |
| A1ZN34.SA | AstraZeneca PLC | $258.63B | Mega cap | +0.13% |
| AMGN34.SA | Amgen Inc. | $239.09B | Mega cap | +47.79% |
| AMGN | Amgen Inc. | $238.06B | Mega cap | +56.24% |
| TMO | Thermo Fisher Scientific Inc. | $234.31B | Mega cap | +30.17% |
| TMOS34.SA | Thermo Fisher Scientific Inc. | $231.47B | Mega cap | +22.22% |
| N1VO34.SA | Novo Nordisk A/S | $208.90B | Mega cap | −17.86% |
| NVO | Novo Nordisk A/S | $208.63B | Mega cap | −13.32% |
| ABTT34.SA | Abbott Laboratories | $199.23B | Large cap | −16.35% |
| ABT | Abbott Laboratories | $198.74B | Large cap | −11.83% |
| GILD | Gilead Sciences, Inc. | $184.47B | Large cap | +32.51% |
| GILD34.SA | Gilead Sciences, Inc. | $184.15B | Large cap | −79.11% |
| PFIZ34.SA | Pfizer Inc. | $161.53B | Large cap | +11.58% |
| PFE | Pfizer Inc. | $161.30B | Large cap | +18.72% |
| DHER34.SA | Danaher Corporation | $151.72B | Large cap | +0.89% |
| DHR | Danaher Corporation | $151.40B | Large cap | +5.61% |
| BMYB34.SA | Bristol-Myers Squibb Company | $138.65B | Large cap | +40.74% |
| BMY | Bristol-Myers Squibb Company | $138.03B | Large cap | +47.01% |
| S1YK34.SA | Stryker Corporation | $126.60B | Large cap | −19.51% |
| SYK | Stryker Corporation | $126.45B | Large cap | −15.52% |
| MDTC34.SA | Medtronic plc | $118.37B | Large cap | −75.74% |
| MDT | Medtronic plc | $117.78B | Large cap | +2.29% |
| SNY | Sanofi | $108.83B | Large cap | −4.33% |
| G1SK34.SA | GSK plc | $104.64B | Large cap | +27.31% |
| M1CK34.SA | McKesson Corporation | $104.59B | Large cap | −92.49% |
| MCK | McKesson Corporation | $104.54B | Large cap | +31.57% |
| GSK | GSK plc | $104.29B | Large cap | +32.23% |
| HCA | HCA Healthcare, Inc. | $94.76B | Large cap | +5.96% |
| H1CA34.SA | HCA Healthcare, Inc. | $92.89B | Large cap | +2.99% |
| ELV | Elevance Health, Inc. | $87.30B | Large cap | +32.12% |
| E1LV34.SA | Elevance Health, Inc. | $86.53B | Large cap | +21.66% |
| REGN34.SA | Regeneron Pharmaceuticals, Inc. | $85.16B | Large cap | +33.80% |
| REGN | Regeneron Pharmaceuticals, Inc. | $83.89B | Large cap | +39.36% |
| CI | The Cigna Group | $74.22B | Large cap | −4.84% |
| C1IC34.SA | The Cigna Group | $73.39B | Large cap | −85.33% |
| COR | Cencora, Inc. | $62.55B | Large cap | +13.45% |
| TAK | Takeda Pharmaceutical Company Limited | $58.60B | Large cap | +22.68% |
| TAKP34.SA | Takeda Pharmaceutical Company Limited | $57.22B | Large cap | +18.03% |
| C1AH34.SA | Cardinal Health, Inc. | $55.77B | Large cap | +52.41% |
| CAH | Cardinal Health, Inc. | $55.45B | Large cap | +61.05% |
| C1CO34.SA | Cencora, Inc. | $52.41B | Large cap | −12.17% |
| BDX | Becton, Dickinson and Company | $51.81B | Large cap | +25.97% |
| B1DX34.SA | Becton, Dickinson and Company | $51.78B | Large cap | −113.87% |
| HUM | Humana Inc. | $46.96B | Large cap | +33.14% |
| H1UM34.SA | Humana Inc. | $46.72B | Large cap | +24.36% |
| HLN | Haleon plc | $44.72B | Large cap | +6.13% |
| A | Agilent Technologies, Inc. | $43.80B | Large cap | +31.46% |
| A1GI34.SA | Agilent Technologies, Inc. | $39.64B | Large cap | −77.37% |
| RPRX | Royalty Pharma plc | $35.71B | Large cap | +74.00% |
| ALC | Alcon Inc. | $35.13B | Large cap | −10.24% |
| RMD | ResMed Inc. | $34.13B | Large cap | −15.77% |
| GEHC | GE HealthCare Technologies Inc. | $33.35B | Large cap | −1.15% |
| ZTS | Zoetis Inc. | $32.03B | Large cap | −49.50% |
| Z1TS34.SA | Zoetis Inc. | $32.03B | Large cap | −52.31% |
| LH | Labcorp Holdings Inc. | $27.39B | Large cap | +21.14% |
| R1MD34.SA | ResMed Inc. | $27.33B | Large cap | −38.24% |
| DGX | Quest Diagnostics Incorporated | $26.99B | Large cap | +38.12% |
| PHG | Koninklijke Philips N.V. | $26.38B | Large cap | +1.27% |
| WST | West Pharmaceutical Services, Inc. | $24.63B | Large cap | +42.61% |
| STE | STERIS plc | $23.09B | Large cap | −4.41% |
| S1TE34.SA | STERIS plc | $19.75B | Large cap | −18.78% |
| VTRS | Viatris Inc. | $19.35B | Large cap | +66.19% |
| ZBH | Zimmer Biomet Holdings, Inc. | $19.34B | Large cap | −4.32% |
| Z1BH34.SA | Zimmer Biomet Holdings, Inc. | $18.07B | Large cap | −5.04% |
| RDOR3.SA | Rede D'Or São Luiz S.A. | $14.92B | Large cap | +1.37% |
| RVTY | Revvity, Inc. | $13.93B | Large cap | +42.93% |
| BAX | Baxter International Inc. | $13.70B | Large cap | +8.90% |
| B1AX34.SA | Baxter International Inc. | $13.60B | Large cap | +3.61% |
| S1NN34.SA | Smith & Nephew plc | $12.87B | Large cap | −20.44% |
| FMS | Fresenius Medical Care AG | $12.51B | Large cap | −3.21% |
| R1VT34.SA | Revvity, Inc. | $12.50B | Large cap | +22.81% |
| SNN | Smith & Nephew plc | $12.23B | Large cap | −19.49% |
| EHC | Encompass Health Corporation | $11.92B | Large cap | −1.75% |
| T1CH34.SA | Bio-Techne Corporation | $11.51B | Large cap | +23.42% |
| TECH | Bio-Techne Corporation | $11.35B | Large cap | +29.33% |
| U1HS34.SA | Universal Health Services, Inc. | $10.55B | Large cap | −6.44% |
| UHS | Universal Health Services, Inc. | $10.53B | Large cap | −1.76% |
| ENSG | The Ensign Group, Inc. | $10.43B | Large cap | +5.01% |
| RDY | Dr. Reddy's Laboratories Limited | $10.18B | Large cap | −14.19% |
| QUAL3.SA | Qualicorp Consultoria e Corretora de Seguros S.A. | $90.10M | Micro cap | −11.35% |
| CCEL | Cryo-Cell International, Inc. | $34.67M | Micro cap | −3.19% |
| BALM4.SA | Baumer S.A. | $29.30M | Micro cap | +22.57% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.